Naprelan

Product NDC
59630-777
11-digit product format
596300777
Labeler code
59630
Product ID
59630-777_00ea44c7-97e5-426f-b0f2-8884e8bfa7dc
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Naproxen Sodium
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Labeler
Shionogi Inc.
Application
NDA020353
Marketing category
NDA
Marketing start
1996-04-01
Marketing end
0000-00-00
Substance
NAPROXEN SODIUM
Active strength
750 mg/1
Pharmacologic classes
Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
59630-777-032025-02-11C16284748780-19855d018-e9e1-cd31-e053-dbdaa90ab51a15ab6690-53bf-4669-950f-35db4dba8fac
59630-777-032019-11-27C16284748780-19855d018-e9e1-cd31-e053-dbdaa90ab51a15ab6690-53bf-4669-950f-35db4dba8fac

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
59630-777-03EA - Each59630-777dfa4fd9c-994c-493b-8d49-df2f609c5b1b12013-02-13